China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136748

Registration Time: 2026/11/15

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Soochow University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327104

Published by HT Digital Content Services with permission from Health Daily Digest....